We are live on ! Find out more
ICU icon

SeaStar Medical

12 hedge funds and large institutions have $68.3K invested in SeaStar Medical in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1212 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.02%0.01% (-0.01%)

76% less capital invested

Capital invested by funds: $290K → $68.3K (-$221K)

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

ICU Hedge Fund Activity: Q3 2023 in Review

12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q3 2023, worth a combined $68.3K — down 76% from $290K a quarter earlier.

Fund positioning in ICU was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $24.7K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $178K sold.

  • 12 institutional investors held SeaStar Medical (ICU) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $68.3K of SeaStar Medical stock for Q3 2023, down 76% quarter-over-quarter.
  • 5 funds opened new SeaStar Medical positions in Q3 2023 and 5 closed out, a net change of 0 holders.
  • The largest SeaStar Medical buyer in Q3 2023 was Geode Capital Management, an estimated $24.7K added.
  • The largest SeaStar Medical seller in Q3 2023 was Hudson Bay Capital Management, an estimated $178K sold.

Based on aggregated 13F filings for Q3 2023.